174 related articles for article (PubMed ID: 30293914)
1. Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia.
Maduell F; Belmar L; Ugalde J; Laguno M; Martínez-Rebollar M; Ojeda R; Arias M; Rodas L; Rossi F; Llovet LP; González LN; Mallolas J; Londoño MC
Gastroenterol Hepatol; 2019 Mar; 42(3):164-170. PubMed ID: 30293914
[TBL] [Abstract][Full Text] [Related]
2. Real-World Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir/+Dasabuvir±Ribavirin (OBV/PTV/r/+DSV±RBV) Therapy in Recurrent Hepatitis C Virus (HCV) Genotype 1 Infection Post-Liver Transplant: AMBER-CEE Study.
Tronina O; Durlik M; Wawrzynowicz-Syczewska M; Buivydiene A; Katzarov K; Kupcinskas L; Tolmane I; Karpińska E; Pisula A; Karwowska KM; Bolewska B; Jabłkowski M; Rostkowska K; Jakutiene J; Simonova M; Flisiak R
Ann Transplant; 2017 Apr; 22():199-207. PubMed ID: 28386057
[TBL] [Abstract][Full Text] [Related]
3. Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4.
Abad S; Vega A; Hernández E; Mérida E; de Sequera P; Albalate M; Macías N; Milla M; López-Gómez JM
Am J Nephrol; 2017; 45(3):267-272. PubMed ID: 28166520
[TBL] [Abstract][Full Text] [Related]
4. ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.
Andreone P; Colombo MG; Enejosa JV; Koksal I; Ferenci P; Maieron A; Müllhaupt B; Horsmans Y; Weiland O; Reesink HW; Rodrigues L; Hu YB; Podsadecki T; Bernstein B
Gastroenterology; 2014 Aug; 147(2):359-365.e1. PubMed ID: 24818763
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a fixed combination formula of ombitasvir/paritaprevir/ritonavir for hepatitis C virus infection in patients on maintenance haemodialysis.
Morisawa N; Koshima Y; Kuriyama S; Matsuyama M; Hayashi N; Satoh JI; Amemiya M; Yokoo T
Nephrology (Carlton); 2017 Jul; 22(7):562-565. PubMed ID: 28621007
[TBL] [Abstract][Full Text] [Related]
6. Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct-acting antiviral therapy.
Poordad F; Bennett M; Sepe TE; Cohen E; Reindollar RW; Everson G; Phillips RW; Siddique A; Sullivan JG; Pilot-Matias T; Abunimeh M; Cohen DE; Younes Z
J Med Virol; 2019 Jul; 91(7):1307-1312. PubMed ID: 30840774
[TBL] [Abstract][Full Text] [Related]
7. Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial.
Deutsch L; Houri I; Ben-Ari Z; Shlomai A; Veitsman E; Cohen-Ezra O; Issachar A; Mor O; Gozlan Y; Bruck R; Menachem Y; Zelber-Sagi S; Katchman H; Shibolet O
BMC Infect Dis; 2020 Apr; 20(1):264. PubMed ID: 32245397
[TBL] [Abstract][Full Text] [Related]
8. Real-Life Use of 3 Direct-Acting Antiviral Regimen in a Large Cohort of Patients with Genotype-1b HCV Compensated Cirrhosis.
Gheorghe L; Iacob S; Curescu M; Brisc C; Cijevschi C; Caruntu F; Stanciu C; Simionov I; Sporea I; Gheorghe C; Iacob R; Arama V; Sirli R; Trifan A
J Gastrointestin Liver Dis; 2017 Sep; 26(3):275-281. PubMed ID: 28922440
[TBL] [Abstract][Full Text] [Related]
9. Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV).
Isakov V; Paduta D; Viani RM; Enejosa JV; Pasechnikov V; Znoyko O; Ogurtsov P; Bogomolov PO; Maevskaya MV; Chen X; Shulman NS
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1073-1076. PubMed ID: 29762255
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.
Pockros PJ; Reddy KR; Mantry PS; Cohen E; Bennett M; Sulkowski MS; Bernstein DE; Cohen DE; Shulman NS; Wang D; Khatri A; Abunimeh M; Podsadecki T; Lawitz E
Gastroenterology; 2016 Jun; 150(7):1590-1598. PubMed ID: 26976799
[TBL] [Abstract][Full Text] [Related]
11. Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
Ji F; Yeo YH; Wei MT; Ogawa E; Enomoto M; Lee DH; Iio E; Lubel J; Wang W; Wei B; Ide T; Preda CM; Conti F; Minami T; Bielen R; Sezaki H; Barone M; Kolly P; Chu PS; Virlogeux V; Eurich D; Henry L; Bass MB; Kanai T; Dang S; Li Z; Dufour JF; Zoulim F; Andreone P; Cheung RC; Tanaka Y; Furusyo N; Toyoda H; Tamori A; Nguyen MH
J Hepatol; 2019 Sep; 71(3):473-485. PubMed ID: 31096005
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).
Wiegand J; Buggisch P; Mauss S; Boeker KHW; Klinker H; Müller T; Günther R; Serfert Y; Manns MP; Zeuzem S; Berg T; Hinrichsen H; C-Registry GH
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1424-1431. PubMed ID: 31589184
[TBL] [Abstract][Full Text] [Related]
13. Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy.
Grebely J; Conway B; Cunningham EB; Fraser C; Moriggia A; Gane E; Stedman C; Cooper C; Castro E; Schmid P; Petoumenos K; Hajarizadeh B; Marks P; Erratt A; Dalgard O; Lacombe K; Feld JJ; Bruneau J; Daulouede JP; Powis J; Bruggmann P; Matthews GV; Kronborg I; Shaw D; Dunlop A; Hellard M; Applegate TL; Crawford S; Dore GJ;
Int J Drug Policy; 2018 Dec; 62():94-103. PubMed ID: 30384028
[TBL] [Abstract][Full Text] [Related]
14. Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider.
Weil C; Mehta D; Koren G; Pinsky B; Samp JC; Chodick G; Shalev V
J Viral Hepat; 2018 Feb; 25(2):144-151. PubMed ID: 28984012
[TBL] [Abstract][Full Text] [Related]
15. Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection.
Danış N; Toz H; Ünal N; Yılmaz M; Turan İ; Günşar F; Karasu Z; Ersöz G; Özkahya M; Akarca US
Turk J Gastroenterol; 2019 Aug; 30(8):695-701. PubMed ID: 31418413
[TBL] [Abstract][Full Text] [Related]
16. Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir and Ribavirin for Hepatitis C Virus Genotype 2-Infected Japanese Patients.
Sato K; Chayama K; Alves K; Toyoda H; Suzuki F; Kato K; Rodrigues L; Zhang X; Setze C; Pilot-Matias T; Burroughs M; Redman R; Kumada H
Adv Ther; 2017 Jun; 34(6):1449-1465. PubMed ID: 28536999
[TBL] [Abstract][Full Text] [Related]
17. Successful Treatment With Direct-Acting Antiviral Agents of Hepatitis C in Patients With End-Stage Renal Disease and Kidney Transplant Recipients.
Özer Etik D; Suna N; Öcal S; Selçuk H; Dağlı Ü; Çolak T; Hilmioğlu F; Boyacıoğlu AS; Haberal M
Exp Clin Transplant; 2019 Feb; 17(1):52-58. PubMed ID: 30719954
[TBL] [Abstract][Full Text] [Related]
18. Paritaprevir/ritonavir/ombitasvir and dasabuvir for the treatment of chronic hepatitis C virus infection.
Cheng EY; Saab S; Holt CD; Busuttil RW
Expert Opin Pharmacother; 2015; 16(18):2835-48. PubMed ID: 26646975
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences.
Örmeci N; Sezgin O; Karaali R; Aygen B; Turan D; Yaras S; Erdem İ; Yildiz O; Karakaya F; Ateş K; Asiller ÖÖ
Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):534-539. PubMed ID: 30672829
[TBL] [Abstract][Full Text] [Related]
20. Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
Feld JJ; Kowdley KV; Coakley E; Sigal S; Nelson DR; Crawford D; Weiland O; Aguilar H; Xiong J; Pilot-Matias T; DaSilva-Tillmann B; Larsen L; Podsadecki T; Bernstein B
N Engl J Med; 2014 Apr; 370(17):1594-603. PubMed ID: 24720703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
